ArticleEuropean radiology2026
Uncovering underdiagnosed emphysema: comparative assessment using clinical CT and micro-CT.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesObjective quantification of emphysema on clinical computed tomography (CT) in patients with chronic obstructive pulmonary disease (COPD) relies primarily on the percentage of low attenuation area (LAA). However, this approach is limited by spatial resolution, potentially leading to underestimation of subtle disease. The mean linear intercept (MLI) is a well-established histological marker of airspace enlargement. We developed an automated micro-CT-based approach to quantify the MLI that is less labour-intensive than existing methods. Micro-CT MLI was systematically compared with clinical CT LAA and histological MLI. MATERIALS AND
methodsThe study included 89 patients with different disease severities, including never-smokers (n = 15), ever-smokers (n = 9), pre-COPD (n = 19), mild COPD (GOLD I/II, n = 18/12), and severe COPD (GOLD III/IV, n = 3/13). All patients underwent spirometry, clinical CT before surgery, and at least 4 tissue cores per explanted lung specimen were scanned with micro-CT and used for the MLI computation. Histological validation was performed in a representative subset of patients (n = 29).
resultsMLI computed on histology was correlated with micro-CT-based MLI (r = 0.84, p < 0.001). A similar correlation (r = 0.83, p < 0.001) was found between the LAA on clinical CT and the average MLI of a patient on micro-CT. However, 30% of patients with non-elevated LAA (≤ 5%) exhibited elevated MLI on micro-CT, indicating underdiagnosed emphysema on clinical CT. The prevalence of undetected cases was the highest among ever-smokers (22%), pre-COPD patients (26%), and patients with mild COPD (23%).
conclusionMicro-CT enables sensitive quantitative detection of subtle emphysematous changes, revealing important limitations of current clinical CT-based diagnostics. KEY POINTS: Question Is LAA-based emphysema thresholding on clinical CT able to accurately detect mild emphysema? Findings Emphysematous changes were detected in 30% of patients without emphysema on clinical CT, particularly among ever-smokers, pre-COPD, and mild COPD patients. Clinical relevance Micro-CT exposes early emphysematous changes undetectable on clinical CT, enabling refined COPD phenotyping and advancing diagnostic development.
Indexed as
Identifiers
42645341What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.